Skip to main content

Table 3 Participant recommendations to sustain and expand injectable treatment potential for success

From: Patient and clinic staff perspectives on the implementation of a long-acting injectable antiretroviral therapy program in an urban safety-net health system

PLWH (n = 15)

Physician (n = 2)

Clinic Staff (n = 9)

• Remove financial barriers related to insurance and copays

• Provision of real-life data to overcome practice inertia

• Insurance reform

 o Standardize eligibility requirements for injectable treatment across insurance carriers

• Increase access to more patients

• Increase patient eligibility and reach

• Expand clinical eligibility and reach

 o Street medicine integration

 o Include patients in case management and adherence counseling

 o Include the uninsured

 o Patient advertising

• Offer at-home injectable kits

• Patient education

• Patient education to create awareness and available coverage

• Expand staff training and additional physicians should be trained and involved

• Increase timing between shots to bi-annual

• Staffing: Consistent trained nurse staff/no attrition

• Create an autonomous clinic for injectable treatment

• Include other anatomic sites for injections

 

• More stakeholder ownership

 o Designate clinic staff to partake in program ownership

 o Have dedicated staff to manage prior authorizations and the PAP process

 o Dedicated staff to manage injection appointments

• Other formulations of LAI CAB/RPV

 

• Provide case management and support services, especially for medically fragile patients. E.g., patient navigation

  

• Provide a compassionate environment and care

  1. PAP Patient assistance program, LAI CAB/RPV Long-acting injectable cabotegravir plus rilpivirine